#dexta-daps

[ follow ]
#weight-loss #glp-1-drugs #glp-1-medications #obesity-treatment #glp-1 #fda-approval #eli-lilly
#glp-1-agonists
Medicine
fromFuturism
20 hours ago

GLP-1 Drugs Linked to Cognitive Impairment, Though the Reason Why Probably Isn't What You Expect

GLP-1 agonists may increase the risk of cognitive impairment despite their other health benefits.
Medicine
fromwww.theguardian.com
1 month ago

The Guardian view on weight-loss jabs and addiction: there is too much moralising about these remarkable medicines | Editorial

Weight-loss drugs show promise in reducing addiction risk, suggesting they may address shared biological mechanisms between food and drug cravings in the brain.
Medicine
fromFuturism
20 hours ago

GLP-1 Drugs Linked to Cognitive Impairment, Though the Reason Why Probably Isn't What You Expect

GLP-1 agonists may increase the risk of cognitive impairment despite their other health benefits.
Medicine
fromwww.theguardian.com
1 month ago

The Guardian view on weight-loss jabs and addiction: there is too much moralising about these remarkable medicines | Editorial

Weight-loss drugs show promise in reducing addiction risk, suggesting they may address shared biological mechanisms between food and drug cravings in the brain.
more#glp-1-agonists
#peptides
Health
fromABC7 Los Angeles
1 day ago

As unregulated peptides grow in popularity, doctors warn of unknown risks

Unregulated peptide injections are gaining popularity for healing and beauty, but their safety and effectiveness remain unproven.
fromAxios
2 days ago
Public health

RFK Jr.'s peptide push could become next wellness boom

Self-administered peptide injections are gaining popularity for healing, anti-aging, and inflammation reduction, driven by social media and potential regulatory changes.
Health
fromABC7 Los Angeles
1 day ago

As unregulated peptides grow in popularity, doctors warn of unknown risks

Unregulated peptide injections are gaining popularity for healing and beauty, but their safety and effectiveness remain unproven.
Public health
fromAxios
2 days ago

RFK Jr.'s peptide push could become next wellness boom

Self-administered peptide injections are gaining popularity for healing, anti-aging, and inflammation reduction, driven by social media and potential regulatory changes.
more#peptides
Television
fromInsideHook
5 days ago

The Weird Trick That Makes You Want Less Junk Food

Viewing images of unhealthy food can reduce actual consumption among dieters due to a phenomenon called cross-modal satiation.
Psychology
fromwww.theguardian.com
4 days ago

What really controls our appetite hunger, stress or habit?

Hunger, appetite, and fullness are regulated by different brain areas, influencing our eating behaviors and responses to food.
#weight-loss
Psychology
fromPsychology Today
4 weeks ago

What Weight-Loss Drugs Reveal About How We Judge Effort

Visible struggle in weight loss is often misinterpreted as greater effort, while underlying biological and psychological factors play a significant role.
Medicine
fromABC7 New York
3 weeks ago

FDA grants speedy approval to Eli Lilly's weight-loss pill for obesity

Eli Lilly's orforglipron, branded as Foundayo, is a new FDA-approved weight-loss pill expected to be available soon.
Medicine
fromwww.dw.com
1 day ago

Natural molecule could provide Ozempic, Wegovy alternative

New weight-loss treatments like BRP may reduce side effects compared to existing drugs by targeting appetite regulation in the hypothalamus.
Medicine
fromScienceDaily
1 week ago

Stanford scientists discover "natural Ozempic" without side effects

A newly discovered molecule, BRP, reduces appetite and promotes fat loss without the side effects of Ozempic.
Psychology
fromPsychology Today
4 weeks ago

What Weight-Loss Drugs Reveal About How We Judge Effort

Visible struggle in weight loss is often misinterpreted as greater effort, while underlying biological and psychological factors play a significant role.
Medicine
fromwww.bbc.com
2 weeks ago

New light shed on who benefits most from weight-loss jabs

Genetic variations in appetite and digestion can enhance weight loss effectiveness of drugs like Wegovy and Mounjaro.
Medicine
fromABC7 New York
3 weeks ago

FDA grants speedy approval to Eli Lilly's weight-loss pill for obesity

Eli Lilly's orforglipron, branded as Foundayo, is a new FDA-approved weight-loss pill expected to be available soon.
more#weight-loss
#glp-1-medications
Health
fromFast Company
1 month ago

New study of 77,000 patients reveals the hard truth about GLP1s

GLP-1 medications produce temporary weight loss; stopping treatment causes weight regain and return of metabolic complications within 1-2 years.
Alternative medicine
fromFast Company
1 week ago

With GLP1 drug ads everywhere, here's what to know to safely buy them online

GLP-1 medications for weight loss are increasingly advertised, raising concerns about safety and the rise of unregulated alternatives.
Medicine
fromPsychology Today
2 weeks ago

The Dangerous Allure of Compounded GLP-1 Drugs

Compounded GLP-1 medications can be unsafe and unregulated, leading to serious health risks like acute liver failure.
Wellness
fromPsychology Today
1 month ago

GLP-1s and the Thin Ideal

GLP-1 medications in a culture equating thinness with worth risk reinforcing body surveillance, masking eating disorders, and creating harmful weight cycling patterns with psychological consequences.
more#glp-1-medications
Health
fromwww.independent.co.uk
2 days ago

Taking vitamin D supplements has hidden potential benefits for some people

Vitamin D supplements may help prevent type 2 diabetes in individuals with specific genetic variations.
#glp-1
Medicine
fromThe Atlantic
2 weeks ago

A Shot to Lose Weight, Then a Pill to Keep It Off

New GLP-1 pills are less effective than injections but offer convenience for long-term weight management.
Medicine
fromThe Atlantic
2 weeks ago

A Shot to Lose Weight, Then a Pill to Keep It Off

New GLP-1 pills are less effective than injections but offer convenience for long-term weight management.
more#glp-1
Wearables
fromThe Verge
2 weeks ago

A year of continuous glucose monitoring pushed me to the edge

Glucose tracking is increasingly popular among non-diabetics, with many using continuous glucose monitors for health insights.
#glp-1-drugs
Medicine
fromIndependent
1 week ago

'If you are eating six smaller meals, you've doubled your sugar attacks. So you've got increased risk of tooth decay' - Measuring the effects of GLP-1s on Irish society

GLP-1 drugs improve obesity treatment but may contribute to body acceptance issues and societal stigma.
fromBusiness Insider
1 month ago
Healthcare

Eli Lilly is set to release a once-daily pill to rival Ozempic this year. People are losing 15 to 20 pounds on it, but there's a catch.

Medicine
fromFuturism
1 month ago

Scientists Just Found Something Rather Grim That Happens When You Stop Taking GLP-1s

Stopping GLP-1 drugs can quickly reverse health benefits, increasing cardiovascular risks and leading to weight regain and other health issues.
Medicine
fromIndependent
1 week ago

'If you are eating six smaller meals, you've doubled your sugar attacks. So you've got increased risk of tooth decay' - Measuring the effects of GLP-1s on Irish society

GLP-1 drugs improve obesity treatment but may contribute to body acceptance issues and societal stigma.
fromBusiness Insider
1 month ago
Healthcare

Eli Lilly is set to release a once-daily pill to rival Ozempic this year. People are losing 15 to 20 pounds on it, but there's a catch.

Medicine
fromFuturism
1 month ago

Scientists Just Found Something Rather Grim That Happens When You Stop Taking GLP-1s

Stopping GLP-1 drugs can quickly reverse health benefits, increasing cardiovascular risks and leading to weight regain and other health issues.
more#glp-1-drugs
fromwww.npr.org
3 weeks ago

The FDA approves a new obesity pill, giving patients another option

We've created a small molecule chemical which gets in your body very well. It can mimic the effects of the peptide and can be taken more conveniently any time of day without any food or water restrictions.
US news
Healthcare
fromTechCrunch
1 month ago

Riding the GLP-1 boom, VITL lands $7.5M to overhaul cash-pay clinic prescribing | TechCrunch

VITL provides an e-prescribing platform tailored for cash-pay medical businesses, significantly improving prescription management efficiency for clinics.
from24/7 Wall St.
2 weeks ago

Eli Lilly vs. Novo Nordisk: The Obesity Drug Race Has a New Leader

Lilly's fourth quarter revenue reached $19.29 billion, up 42.6% year-over-year, powered almost entirely by two products. Mounjaro generated $7.41 billion, up 110%, while Zepbound added $4.26 billion, up 123%.
Medicine
Medicine
fromwww.theguardian.com
2 weeks ago

Genetics may help explain why results from weight-loss jabs vary, say scientists

Genetic variations in gut hormone pathways may explain differing responses to weight-loss medications like GLP1 receptor agonists.
#obesity
Medicine
fromWIRED
3 weeks ago

FDA Approves Eli Lilly's GLP-1 Pill

The FDA approved Foundayo, a new daily obesity pill by Eli Lilly, expanding options for weight loss treatments alongside injectable GLP-1 medications.
Medicine
fromWIRED
3 weeks ago

FDA Approves Eli Lilly's GLP-1 Pill

The FDA approved Foundayo, a new daily obesity pill by Eli Lilly, expanding options for weight loss treatments alongside injectable GLP-1 medications.
more#obesity
#fda-approval
Medicine
fromwww.scientificamerican.com
3 weeks ago

The weight-loss drug rivalry heats up as another GLP-1 pill gains FDA approval

Eli Lilly's orforglipron received FDA approval as a weight loss treatment, showing significant weight loss in clinical trials.
Medicine
fromwww.scientificamerican.com
3 weeks ago

The weight-loss drug rivalry heats up as another GLP-1 pill gains FDA approval

Eli Lilly's orforglipron received FDA approval as a weight loss treatment, showing significant weight loss in clinical trials.
more#fda-approval
Healthcare
fromThe Atlantic
2 months ago

GLP-1 Envy Was Just the Beginning

Telehealth companies market paid services that promise wealthy-style, personalized concierge care, highlighting and monetizing the divide between elite proactive care and reactive mainstream care.
Public health
fromBBC
2 months ago

Inside Health - What are the side effects of weight loss drugs? - BBC Sounds

Weight loss drugs were used by over 1.5 million UK adults in 2024–25 and can cause side effects including nausea and painful gallstones.
Medicine
fromJezebel
4 weeks ago

First It Was Mini-Livers; Now Science Can Give You a Bonus Pancreas as Well?

New studies show potential for injectable mini-livers and implantable devices with pancreatic cells to aid liver disease and diabetes management.
Health
fromIrish Independent
2 months ago

Real Health: From Stigma to Science: Aimee Donnellan on Ozempic

Weight-loss drugs like Ozempic rapidly shifted from a niche medical treatment to a global phenomenon reshaping business, society, and the food industry.
Public health
fromwww.bbc.com
2 months ago

Could weight-loss jabs be behind rising gallbladder removals?

Specialist doctors call for more research into a possible link between GLP-1 weight-loss injections and rising gallbladder removals and gallstones.
Health
fromBusiness Insider
2 months ago

My two weeks in sugar jail

Continuous glucose monitoring reveals blood sugar fluctuations, but limited evidence links stabilizing glucose in healthy people to sustained energy improvement or weight loss.
Medicine
fromwww.scientificamerican.com
1 month ago

Experimental GLP-3 weight loss drug retatrutide shows promising results in clinical trial

Retatrutide, a triple-receptor GLP-3 agonist drug, achieved up to 36.6 pounds of average weight loss and improved blood sugar control in phase 3 clinical trials for type 2 diabetes.
#glp-1-receptor-agonists
Medicine
fromwww.theguardian.com
1 month ago

GLP-1 diabetes drugs could stop anxiety and depression worsening, study finds

GLP-1 receptor agonists, particularly semaglutide and liraglutide, reduce the risk of worsening anxiety and depression in people with diabetes.
Medicine
fromNature
1 month ago

Can weight-loss pills replace injectables? What the science says

Oral anti-obesity pills based on GLP-1 receptor agonists are entering the market, offering needle-free alternatives to injectable weight-loss drugs, though they produce less weight loss than injections.
Medicine
fromwww.theguardian.com
1 month ago

GLP-1 diabetes drugs could stop anxiety and depression worsening, study finds

GLP-1 receptor agonists, particularly semaglutide and liraglutide, reduce the risk of worsening anxiety and depression in people with diabetes.
Medicine
fromNature
1 month ago

Can weight-loss pills replace injectables? What the science says

Oral anti-obesity pills based on GLP-1 receptor agonists are entering the market, offering needle-free alternatives to injectable weight-loss drugs, though they produce less weight loss than injections.
more#glp-1-receptor-agonists
Medicine
fromwww.scientificamerican.com
1 month ago

Drugs like Ozempic are improving kidney treatment and changing lives

GLP-1 receptor agonists, finerenone, and SGLT2 inhibitors represent breakthrough treatments for chronic kidney disease, with combined therapy potentially adding decades to patients' lives.
Medicine
fromIndependent
1 month ago

Weight-loss jab Wegovy has 'highest risk of rare eye stroke', study finds

Wegovy carries nearly five times higher risk of eye stroke and sudden sight loss compared to Ozempic, with men facing three times greater risk than women.
[ Load more ]